Novo Nordisk A/S (NOVC)
Market Closed
10 Aug, 15:30
XETRA 
€
40. 80
+0.09
+0.2211%
€
- Market Cap
48.26 P/E Ratio
0.32% Div Yield
109,876 Volume
0 Eps
€ 40.71
Previous Close Want to track NOVC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | 0.23 |
| | | - | 0.26 |
| | | - | 0.26 |
| | | - | 0.25 |
| | | - | 0.22 |
| | | - | 0.22 |
| | | - | 0.22 |
| | | - | 0.25 |
| | | - | 0.17 |
| | | - | 0.17 |
| | | - | 0.18 |
| | | - | 0.16 |
| | | - | 0.15 |
| | | - | 0.16 |
| | | - | 0.17 |
| | | - | 0.15 |
NOVC Earnings Reports FAQ
What is the earnings per share (EPS) for NOVC?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 3 years, the earnings growth rate has been approximately 16.43%, reflecting the NOVC's performance and XETRA market conditions.
When is the next earnings release date?
Novo Nordisk A/S has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Novo Nordisk A/S are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NOVC at this time, as Novo Nordisk A/S has no recent EPS data to calculate it.
